ArticlePloS one2025
RETRACTED: LGD_Net: Capsule network with extreme learning machine for classification of lung diseases using CT scans.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
- Retraction · 2026-04-08Concerns/Issues about Article · Concerns/Issues about Data · Concerns/Issues about Results and/or Conclusions · Euphemisms for Plagiarism · Objections by Author(s) · Plagiarism of Image ·
- Retracted
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung diseases (LGDs) are related to an extensive range of lung disorders, including pneumonia (PNEUM), lung cancer (LC), tuberculosis (TB), and COVID-19 etc. The diagnosis of LGDs is performed by using different medical imaging such as X-rays, CT scans, and MRI. However, LGDs contain similar symptoms such as fever, cough, and sore throat, making it challenging for radiologists to classify these LGDs. If LGDs are not diagnosed at their initial phase, they may produce severe complications or even death. An automated classifier is required for the classification of LGDs. Thus, this study aims to propose a novel model named lung diseases classification network (LGD_Net) based on the combination of a capsule network (CapsNet) with the extreme learning machine (ELM) for the classification of five different LGDs such as PNEUM, LC, TB, COVID-19 omicron (COO), and normal (NOR) using CT scans. The LGD_Net model is trained and tested on the five publicly available benchmark datasets. The datasets contain an imbalanced distribution of images; therefore, a borderline SMOTE (BL_SMT) approach is applied to handle this problem. Additionally, the affine transformation methods are used to enhance LGD datasets. The performance of the LGD_Net is compared with four CNN-based baseline models such as Vgg-19 (D1), ResNet-101 (D2), Inception-v3 (D3), and DenseNet-169 (D4). The LGD_Net model achieves an accuracy of 99.71% in classifying LGDs using CT scans. While the other models such as D1, D2, D3, and D4 attains an accuracy of 91.21%, 94.39%, 93.96%, and 93.82%, respectively. The findings demonstrate that the LGD_Net model works significantly as compared to D1, D2, D3, and D4 as well as state-of-the-art (SOTA). Thus, this study concludes that the LGD_Net model provides significant assistance to radiologists in classifying several LGDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.